Products Details and Description of Trima Lip Tablets : Trims The Lipid Level In Nature’s way, 60 Tablet
TrimaLip Tablets is a scientifically developed formula that maintains optimum lipid metabolism and keeps the level of cholesterol in control.
TrimaLIP is rich in flavonoids which maintain the vascularity of blood vessels and are helpful in maintaining healthy levels of triglycerides, low-density lipoprotein, and high-density lipoprotein cholesterol in the body.
TrimaLIP reduces lipid peroxidation by exerting anti-oxidant protection on vital organs
Acts as an anti-hyperlipidemic and as a potential lipid regulator
- Down regulates HMG-CoA reductase enzyme, thereby reducing cholesterol synthesis
- Down regulates glucose-6-phosphate dehydrogenase enzyme, thereby reducing triglyceride synthesis
- Decreases Acetyl-CoA Carboxylase enzyme, thereby reducing fatty acid, triacylglycerols synthesis
- Inhibits lipogenesis and helps in reducing body weight
- Increases the activity of LCAT (Lecithin Cholesterol Acyltransferase) enzyme which by RCT Pathway, reduces high cholesterol.
- Lowers the level of bad cholesterol by reducing intestinal absorption of dietary cholesterol and increases faecal excretion.
Exerts Cardio protective action, Nourishes vital organs naturally
- Prevents cholesterol deposit on coronary artery wall, thus helping manage Atherosclerosis
- Restores the cardioprotective High Density Lipid (HDL)
- Supports liver health by restoring the levels of AST, ALP, and LDH levels and promotes Hepatic Lipid clearance
- Provides a cytoprotective effect and reduces lipid peroxidation by exerting anti-oxidant action to protect vital organs
Unique salient features of TrimaLIP :
- TrimaLIP reduces lipid peroxidation.
- Maintains the vascularity of blood vessels.
- Boosts Lipid metabolism
- TrimaLIP protects vital organs.
- Supplements powerful phytoactives & minerals.
- Safe on long-term usage.
-
Indications :
- Hyperlipidemia
- Poor lipid metabolism
- Disturbed Lipid profile
- Oxidative stress.
Reviews
There are no reviews yet.